Alkem Laboratories Limited (NSE:ALKEM)
India · Delayed Price · Currency is INR 5,144.50
-113.00 (-2.15%)
At close: Mar 23, 2026
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 615.1 billion as of March 23, 2026. Its market cap has increased by 10.72% in one year.
Market Cap
615.10B
Enterprise Value
591.79B
Revenue
142.53B
Ranking
n/a
PE Ratio
25.94
Stock Price
5,144.50
Market Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 615.10B, an increase of 272.33%. That is a compound annual growth rate of 13.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 628.61B | -4.52% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.62T |
| Cipla | 1.01T |
| Zydus Lifesciences | 896.05B |
| Mankind Pharma | 825.66B |
| Aurobindo Pharma | 750.05B |
| Glenmark Pharmaceuticals | 615.23B |
| Laurus Labs | 532.95B |
| Ipca Laboratories | 391.95B |